Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Foley

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Proteomics. Clinical Applications|February 27, 2023
Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosisFerhan Qureshi, Wayne Hu, Louisa Loh, et al.
Free Radical Biology & Medicine|September 23, 2015
Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cellsKah Tan Allen, Helen Chin-Sinex, Thomas DeLuca, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Drug-eluting stent coatingsJudit E Puskas, Lyn G Muñoz-Robledo, Robert A Hoerr, et al.
The Journal of Endocrinology|April 10, 2004
Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytesYong-Mee Cho, Davina A Lewis, Peter F Koltz, et al.
Oncology Research|January 29, 2003
Constitutive production of parathyroid hormone-related protein (PTHrP) by fibroblasts derived from normal and pathological human breast tissueMagali Cros, Christophe Cataisson, Yong Mee Cho, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Multiple Sclerosis and Related Disorders|January 6, 2020
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosisJohn Foley, Cynthia Carrillo-Infante, Jonathan Smith, et al.
Proceedings. Biological Sciences|July 3, 2015
Cross-generational impact of a male murine pheromone 2-sec-butyl-4,5- dihydrothiazole in female miceSachiko Koyama, Helena A Soini, James Wager-Miller, et al.
Urology|March 18, 2003
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomogramsKevin J Gancarczyk, Hongyu Wu, David G McLeod, et al.
The Journal of Urology|April 11, 2003
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJason C Massengill, Leon Sun, Judd W Moul, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Proteomics. Clinical Applications|February 27, 2023
Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosisFerhan Qureshi, Wayne Hu, Louisa Loh, et al.
Free Radical Biology & Medicine|September 23, 2015
Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cellsKah Tan Allen, Helen Chin-Sinex, Thomas DeLuca, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Drug-eluting stent coatingsJudit E Puskas, Lyn G Muñoz-Robledo, Robert A Hoerr, et al.
The Journal of Endocrinology|April 10, 2004
Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytesYong-Mee Cho, Davina A Lewis, Peter F Koltz, et al.
Oncology Research|January 29, 2003
Constitutive production of parathyroid hormone-related protein (PTHrP) by fibroblasts derived from normal and pathological human breast tissueMagali Cros, Christophe Cataisson, Yong Mee Cho, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Multiple Sclerosis and Related Disorders|January 6, 2020
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosisJohn Foley, Cynthia Carrillo-Infante, Jonathan Smith, et al.
Proceedings. Biological Sciences|July 3, 2015
Cross-generational impact of a male murine pheromone 2-sec-butyl-4,5- dihydrothiazole in female miceSachiko Koyama, Helena A Soini, James Wager-Miller, et al.
Urology|March 18, 2003
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomogramsKevin J Gancarczyk, Hongyu Wu, David G McLeod, et al.
The Journal of Urology|April 11, 2003
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJason C Massengill, Leon Sun, Judd W Moul, et al.
Pageof 9